These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 25801509

  • 1. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.
    Yoshida M, Kitaoka S, Egawa N, Yamane M, Ikeda R, Tsukita K, Amano N, Watanabe A, Morimoto M, Takahashi J, Hosoi H, Nakahata T, Inoue H, Saito MK.
    Stem Cell Reports; 2015 Apr 14; 4(4):561-8. PubMed ID: 25801509
    [Abstract] [Full Text] [Related]

  • 2. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K, Funato M, Kato Z, Seki J, Kawase C, Tamai Y, Ono Y, Nagahara Y, Noda Y, Kameyama T, Ando S, Tsuruma K, Shimazawa M, Hara H, Kaneko H.
    Stem Cells Transl Med; 2016 Feb 14; 5(2):152-63. PubMed ID: 26683872
    [Abstract] [Full Text] [Related]

  • 3. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X, Li JJ, Qian WJ, Zhang QJ, Wang ZF, Lu YQ, Dong EL, He J, Wang N, Ma LX, Chen WJ.
    Oncotarget; 2017 Jun 27; 8(26):42030-42042. PubMed ID: 28159932
    [Abstract] [Full Text] [Related]

  • 4. Spinal muscular atrophy patient-derived motor neurons exhibit hyperexcitability.
    Liu H, Lu J, Chen H, Du Z, Li XJ, Zhang SC.
    Sci Rep; 2015 Jul 20; 5():12189. PubMed ID: 26190808
    [Abstract] [Full Text] [Related]

  • 5. Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient.
    Chang T, Zheng W, Tsark W, Bates S, Huang H, Lin RJ, Yee JK.
    Stem Cells; 2011 Dec 20; 29(12):2090-3. PubMed ID: 21956898
    [Abstract] [Full Text] [Related]

  • 6. Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches.
    Nizzardo M, Simone C, Dametti S, Salani S, Ulzi G, Pagliarani S, Rizzo F, Frattini E, Pagani F, Bresolin N, Comi G, Corti S.
    Sci Rep; 2015 Jun 30; 5():11746. PubMed ID: 26123042
    [Abstract] [Full Text] [Related]

  • 7. Pluripotent stem cell-based models of spinal muscular atrophy.
    Frattini E, Ruggieri M, Salani S, Faravelli I, Zanetta C, Nizzardo M, Simone C, Magri F, Corti S.
    Mol Cell Neurosci; 2015 Jan 30; 64():44-50. PubMed ID: 25511182
    [Abstract] [Full Text] [Related]

  • 8. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D, Pyles N, Crawford TO, Swoboda KJ, Patitucci TN, Ebert AD, Sumner CJ, Ko CP, Lorson CL.
    Hum Mol Genet; 2015 Jul 15; 24(14):4094-102. PubMed ID: 25911676
    [Abstract] [Full Text] [Related]

  • 9. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
    Xu CC, Denton KR, Wang ZB, Zhang X, Li XJ.
    Dis Model Mech; 2016 Jan 15; 9(1):39-49. PubMed ID: 26586529
    [Abstract] [Full Text] [Related]

  • 10. Defects in neuromuscular junction remodelling in the Smn(2B/-) mouse model of spinal muscular atrophy.
    Murray LM, Beauvais A, Bhanot K, Kothary R.
    Neurobiol Dis; 2013 Jan 15; 49():57-67. PubMed ID: 22960106
    [Abstract] [Full Text] [Related]

  • 11. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL, Chen TH, Hsu YY, Cheng YH, Juang BT, Jong YJ.
    PLoS One; 2016 Jan 15; 11(4):e0154723. PubMed ID: 27124114
    [Abstract] [Full Text] [Related]

  • 12. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.
    Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT, Monani UR.
    Hum Mol Genet; 2008 Aug 15; 17(16):2552-69. PubMed ID: 18492800
    [Abstract] [Full Text] [Related]

  • 13. Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model.
    Ando S, Funato M, Ohuchi K, Kameyama T, Inagaki S, Seki J, Kawase C, Tsuruma K, Shimazawa M, Kaneko H, Hara H.
    Eur J Pharmacol; 2017 Nov 05; 814():161-168. PubMed ID: 28826912
    [Abstract] [Full Text] [Related]

  • 14. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK, Caine C, Awano T, Herbst R, Monani UR.
    Hum Mol Genet; 2017 Jul 01; 26(13):2377-2385. PubMed ID: 28379354
    [Abstract] [Full Text] [Related]

  • 15. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
    Feng Z, Lam S, Tenn ES, Ghosh AS, Cantor S, Zhang W, Yen PF, Chen KS, Burden S, Paushkin S, Ayalon G, Ko CP.
    Int J Mol Sci; 2021 Jul 27; 22(15):. PubMed ID: 34360794
    [Abstract] [Full Text] [Related]

  • 16. Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons.
    Boza-Morán MG, Martínez-Hernández R, Bernal S, Wanisch K, Also-Rallo E, Le Heron A, Alías L, Denis C, Girard M, Yee JK, Tizzano EF, Yáñez-Muñoz RJ.
    Sci Rep; 2015 Jun 26; 5():11696. PubMed ID: 26114395
    [Abstract] [Full Text] [Related]

  • 17. The Protective Effects of Levetiracetam on a Human iPSCs-Derived Spinal Muscular Atrophy Model.
    Ando S, Funato M, Ohuchi K, Inagaki S, Sato A, Seki J, Kawase C, Saito T, Nishio H, Nakamura S, Shimazawa M, Kaneko H, Hara H.
    Neurochem Res; 2019 Jul 26; 44(7):1773-1779. PubMed ID: 31102025
    [Abstract] [Full Text] [Related]

  • 18. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
    de la Fuente S, Sansa A, Hidalgo I, Vivancos N, Romero-Guevara R, Garcera A, Soler RM.
    Cell Death Dis; 2020 Jun 25; 11(6):487. PubMed ID: 32587237
    [Abstract] [Full Text] [Related]

  • 19. Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy.
    Courtney NL, Mole AJ, Thomson AK, Murray LM.
    Cell Death Dis; 2019 Jul 04; 10(7):515. PubMed ID: 31273192
    [Abstract] [Full Text] [Related]

  • 20. Synaptic defects in type I spinal muscular atrophy in human development.
    Martínez-Hernández R, Bernal S, Also-Rallo E, Alías L, Barceló MJ, Hereu M, Esquerda JE, Tizzano EF.
    J Pathol; 2013 Jan 04; 229(1):49-61. PubMed ID: 22847626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.